相似文献
1
Trending Speculations of Tumor-Initiating Cells in Squamous Cell Cancers of Head and Neck.
Int J Stem Cells. 2017 May 30;10(1):21-27. doi: 10.15283/ijsc16065.
2
Cancer stem cells in head and neck squamous cell carcinoma.
Otolaryngol Pol. 2014 May-Jun;68(3):105-11. doi: 10.1016/j.otpol.2013.10.010. Epub 2013 Nov 5.
3
Current understanding of cancer stem cells: Review of their radiobiology and role in head and neck cancers.
Head Neck. 2017 Sep;39(9):1920-1932. doi: 10.1002/hed.24848. Epub 2017 Jun 23.
4
Stem cells in head and neck squamous cell carcinoma.
Br J Oral Maxillofac Surg. 2011 Oct;49(7):503-6. doi: 10.1016/j.bjoms.2010.07.016. Epub 2010 Sep 15.
5
Attenuation of cancer-initiating cells stemness properties by abrogating S100A4 calcium binding ability in head and neck cancers.
Oncotarget. 2016 Nov 29;7(48):78946-78957. doi: 10.18632/oncotarget.12935.
6
5T4-Targeted Therapy Ablates Cancer Stem Cells and Prevents Recurrence of Head and Neck Squamous Cell Carcinoma.
Clin Cancer Res. 2017 May 15;23(10):2516-2527. doi: 10.1158/1078-0432.CCR-16-1834. Epub 2016 Oct 25.
7
Wnt/β-catenin signalling maintains self-renewal and tumourigenicity of head and neck squamous cell carcinoma stem-like cells by activating Oct4.
J Pathol. 2014 Sep;234(1):99-107. doi: 10.1002/path.4383. Epub 2014 Jul 23.
8
IL-6 Inhibition With MEDI5117 Decreases The Fraction of Head and Neck Cancer Stem Cells and Prevents Tumor Recurrence.
Neoplasia. 2016 May;18(5):273-281. doi: 10.1016/j.neo.2016.03.004. Epub 2016 Apr 15.
9
The Role of HPV in Head and Neck Cancer Stem Cell Formation and Tumorigenesis.
Cancers (Basel). 2016 Feb 19;8(2):24. doi: 10.3390/cancers8020024.
10
Plasminogen activator inhibitor-1 as regulator of tumor-initiating cell properties in head and neck cancers.
Head Neck. 2016 Apr;38 Suppl 1:E895-904. doi: 10.1002/hed.24124. Epub 2015 Jul 16.
引用本文的文献
1
USP28: Oncogene or Tumor Suppressor? A Unifying Paradigm for Squamous Cell Carcinoma.
Cells. 2021 Oct 4;10(10):2652. doi: 10.3390/cells10102652.
本文引用的文献
1
Aldehyde dehydrogenase 1A1 in stem cells and cancer.
Oncotarget. 2016 Mar 8;7(10):11018-32. doi: 10.18632/oncotarget.6920.
2
Aldehyde dehydrogenase as a marker and functional mediator of metastasis in solid tumors.
Clin Exp Metastasis. 2016 Jan;33(1):97-113. doi: 10.1007/s10585-015-9755-9. Epub 2015 Oct 7.
3
Identifying and targeting tumor-initiating cells in the treatment of breast cancer.
Endocr Relat Cancer. 2015 Jun;22(3):R135-55. doi: 10.1530/ERC-14-0447. Epub 2015 Apr 15.
4
The cancer stem cell niche: how essential is the niche in regulating stemness of tumor cells?
Cell Stem Cell. 2015 Mar 5;16(3):225-38. doi: 10.1016/j.stem.2015.02.015.
5
CD44 as a potential diagnostic tumor marker.
Saudi Med J. 2015 Mar;36(3):273-9. doi: 10.15537/smj.2015.3.9622.
6
Evaluation of CD44 variant expression in oral, head and neck squamous cell carcinomas using a triple approach and its clinical significance.
Int J Immunopathol Pharmacol. 2014 Jul-Sep;27(3):337-49. doi: 10.1177/039463201402700304.
7
Refining the role for adult stem cells as cancer cells of origin.
Trends Cell Biol. 2015 Jan;25(1):11-20. doi: 10.1016/j.tcb.2014.08.008. Epub 2014 Sep 18.
8
Intratumor heterogeneity: nature and biological significance.
Biochemistry (Mosc). 2013 Nov;78(11):1201-15. doi: 10.1134/S0006297913110011.
9
Significance of CD44 expression in head and neck cancer: a systemic review and meta-analysis.
BMC Cancer. 2014 Jan 13;14:15. doi: 10.1186/1471-2407-14-15.
10
Cancer stem cell markers in head and neck squamous cell carcinoma.
Stem Cells Int. 2013;2013:319489. doi: 10.1155/2013/319489. Epub 2013 Mar 3.
Zotero 插件